Prevalence of Trichomonas vaginalis in Urine Samples of Women Attending Chukwuemeka Odumegwu Ojukwu University Teaching Hospital, Awka, Southeastern Nigeria

Trichomonas vaginalis is transmitted sexually in humans affecting both male and female genital tracts. A cross sectional study to determine the prevalence of T. vaginalis infection among women attending Chukwuemeka Odumegwu Ojukwu University Teaching Hospital (COOUTH) Awka, Anambra State was conducted between November 2021 and January 2022.  A total of 200 apparently healthy women between the ages of 19 – 42 years volunteered and participated in the study. The study participants included pregnant and non-pregnant women, married, singles and widows from various occupations. Their urine samples were collected, centrifuged and examined under the microscope within 2 hours of collection. Diagnosis was made by detection of T. vaginalis in the wet preparation of urine deposits. An overall prevalence of 3.0% was observed among the study participants.  Prevalence of T. vaginalis was highest (5.9%) among the age group 25-30 years and no infection was observed among the age group 37-42 years. There was no significant difference in the prevalence of infection among the age groups (P>0.05).  Highest prevalence of 3.2% was observed among pregnant women while the least (2.7%) was observed in non-pregnant women. There was no significant difference in the prevalence of infection between pregnant and non-pregnant groups (P>0.05). The highest prevalence (7.5%) was observed among the students while no infection was observed among the civil servants. There was also no significant difference in the prevalence of infection among the occupational groups (P>0.05).  Married women recorded the highest prevalence (3.3%) and no infection was observed among the widows. There was no significant difference in the prevalence of infection in different marital status (P>0.05).  Asymptomatic T. vaginalis infection is common in pregnant women. Routine screening for this infection during pregnancy is recommended in order to reduce potential adverse pregnancy outcomes.